Compare EOG Resources Inc (EOG) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EOG Resources Inc vs TG Therapeutics Inc — how do they compare? EOG Resources Inc trades at $148.16 (market cap $77.90B), while TG Therapeutics Inc trades at $55.37 (market cap $8.16B). The key difference: EOG Resources Inc is far larger — about 9.5× TG Therapeutics Inc's market cap, and EOG Resources Inc pays a 2.75% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold EOG Resources Inc for 59 Days and TG Therapeutics Inc for 16 Days on average.
| EOG | TGTX | |
|---|---|---|
Market Cap | $77.90B | $8.16B |
Volume | 2,930,386 | 1,735,121 |
Sector | Energy | Health |
52-Week High | $153.74 | $59.06 |
52-Week Low | $101.78 | $26.94 |
Typical Hold Time | 59 Days | 16 Days |
Enterprise Value | $81.24B | $8.37B |
Dividend Yield | 2.75% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $148.51, up 2.98% today, with a bullish technical signal from moving averages and strong analyst support. The company demonstrates robust profitability with a 25.81% net income margin and 22.51% ROE, though revenue declined to $22.58B in 2025. Recent earnings beats and a consensus price target of $164.77 highlight positive momentum, while cash flow trends show significant investing outflows for growth.
The outlook for EOG is favorable given its low P/E of 11.56, consistent dividend payments, and projected 2026 revenue growth to $26.6B. Key risks include oil price volatility and high capital expenditures, but strong institutional ownership and zero sell ratings underscore confidence in its disciplined capital allocation and operational execution.
TG Therapeutics (TGTX) trades at $53.34, up 0.74% today, but faces bearish technical signals despite strong profitability metrics like a 55.22% net income margin. Recent earnings misses and a shareholder investigation create headwinds, though revenue growth and a high analyst buy consensus of 84.62% suggest underlying strength. The stock's current price is near key support at $52, with resistance at $54.
The outlook is mixed: robust revenue growth and institutional buying support upside toward the $80.50 consensus target, but earnings misses and legal risks pose challenges. Investors should weigh the company's MS therapy momentum against execution and regulatory uncertainties for balanced risk-reward assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
